Roon a New York City-based company dedicated to providing accessible health guidance, has successfully raised $15 million in Series A funding. The investment round was led by notable venture capital firms FirstMark Capital and Forerunner Ventures, with additional support from early investors TMV and Sequoia Capital.
Roon’s innovative platform aims to bridge the gap between the healthcare people need and the trustworthy information they seek. By providing personalized guidance and support, Roon empowers individuals to steer complex health issues with confidence.
Since its launch 18 months ago, Roon has already made a significant impact on the lives of numerous individuals and families. The platform has:
1. Guided families through serious illnesses
2. Supported couples navigating IVF
3. Connected women with treatments for conditions like PCOS and endometriosis
With the freshly secured funding, Roon plans to expand its platform to cover hundreds of conditions, including critical areas like:
1. Women’s health
2. Cancer
3. Neurology
4. Metabolic health
5. Pediatrics
Roon has established partnerships with physicians from over 50 esteemed institutions, including:
1. Harvard
2. Stanford
3. UCSF
4. Weill Cornell
5. Columbia
These collaborations enable Roon to scale the expertise of leading medical professionals and provide trustworthy guidance to individuals worldwide.
Conclusion
Roon’s $15 million Series A funding marks a significant milestone in the company’s mission to simplify access to trustworthy health guidance. With its expanding platform and partnerships with renowned medical institutions, Roon is poised to make a lasting impact on the healthcare landscape.